D. Kilmer, R. Abresch, M. Mccrory, G. Carter, W. Fowler et al., Facioscapulohumeral Muscular Dystrophy, American Journal of Physical Medicine & Rehabilitation, vol.74, issue.Supplement 1, pp.131-140, 1995.
DOI : 10.1097/00002060-199509001-00007

R. Tawil and S. Van-der-maarel, Facioscapulohumeral muscular dystrophy, Muscle & Nerve, vol.44, issue.1, pp.1-15, 2006.
DOI : 10.1002/mus.20522
URL : https://hal.archives-ouvertes.fr/hal-00770764

S. Attarian, E. Salort-campana, K. Nguyen, A. Behin, A. Urtizberea et al., Recommendations for the management of facioscapulohumeral muscular dystrophy in 2011, Revue Neurologique, vol.168, issue.12, 2011.
DOI : 10.1016/j.neurol.2011.11.008

M. Sarfarazi, C. Wijmenga, M. Upadhyaya, B. Weiffenbach, and C. Hyser, Regional mapping of facioscapulohumeral muscular dystrophy gene on 4q35: combined analysis of an international consortium, Am J Hum Genet, vol.51, pp.396-403, 1992.

J. Van-deutekom, C. Wijmenga, E. Van-tienhoven, A. Gruter, and J. Hewitt, FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit, Human Molecular Genetics, vol.2, issue.12, pp.2037-2079, 1993.
DOI : 10.1093/hmg/2.12.2037

C. Wijmenga, R. Frants, O. Brouwer, P. Moerer, and J. Weber, Location of facioscapulohumeral muscular dystrophy gene on chromosome 4, The Lancet, vol.336, issue.8716, pp.651-654, 1990.
DOI : 10.1016/0140-6736(90)92148-B

P. Lunt, J. Noades, M. Upadhyaya, M. Sarfarazi, and P. Harper, Evidence against location of the gene for facioscapulohumeral muscular dystrophy on the distal long arm of chromosome 14, Journal of the Neurological Sciences, vol.88, issue.1-3, pp.287-92, 1988.
DOI : 10.1016/0022-510X(88)90225-0

R. Lemmers, R. Tawil, L. Petek, J. Balog, and G. Block, Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2, Nature Genetics, vol.867, issue.12, pp.1370-1374, 2012.
DOI : 10.1038/nprot.2006.27
URL : https://hal.archives-ouvertes.fr/hal-00770764

S. Sacconi, R. Lemmers, J. Balog, . Van-der, P. Vliet et al., The FSHD2 Gene SMCHD1 Is a Modifier of Disease Severity in Families Affected by FSHD1, The American Journal of Human Genetics, vol.93, issue.4, pp.744-51, 2013.
DOI : 10.1016/j.ajhg.2013.08.004
URL : https://hal.archives-ouvertes.fr/hal-00868887

J. Winston, L. Duerden, M. Mort, I. Frayling, and M. Rogers, Identification of two novel SMCHD1 sequence variants in families with FSHD-like muscular dystrophy, European Journal of Human Genetics, vol.23, issue.1, pp.67-71, 2014.
DOI : 10.1038/nature11011

R. Tawil, S. Van-der-maarel, and S. Tapscott, Facioscapulohumeral Dystrophy, p.24940479, 2014.
DOI : 10.1016/B978-0-12-410529-4.00097-8
URL : https://hal.archives-ouvertes.fr/hal-00811730

S. Van-der-maarel, D. Miller, R. Tawil, G. Filippova, and S. Tapscott, Facioscapulohumeral muscular dystrophy, Current Opinion in Neurology, vol.25, issue.5, pp.614-634, 2012.
DOI : 10.1097/WCO.0b013e328357f22d
URL : https://hal.archives-ouvertes.fr/hal-00480367

N. Broucqsault, J. Morere, M. Gaillard, J. Dumonceaux, and J. Torrents, Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy, Human Molecular Genetics, vol.22, issue.20, pp.4206-4220, 2013.
DOI : 10.1093/hmg/ddt272
URL : https://hal.archives-ouvertes.fr/hal-00843503

M. Ferreboeuf, V. Mariot, B. Bessieres, A. Vasiljevic, and T. Attie-bitach, DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles, Human Molecular Genetics, vol.23, issue.1, pp.171-181, 2014.
DOI : 10.1093/hmg/ddt409
URL : https://hal.archives-ouvertes.fr/hal-00868855

W. Townley-tilson, T. Callis, and D. Wang, MicroRNAs 1, 133, and 206: Critical factors of skeletal and cardiac muscle development, function, and disease, The International Journal of Biochemistry & Cell Biology, vol.42, issue.8, pp.1252-1257, 2010.
DOI : 10.1016/j.biocel.2009.03.002

C. Ritz and A. Spiess, qpcR: an R package for sigmoidal model selection in quantitative real-time polymerase chain reaction analysis, Bioinformatics, vol.24, issue.13, pp.1549-51, 2008.
DOI : 10.1093/bioinformatics/btn227

P. Mestdagh, P. Van-vlierberghe, D. Weer, A. Muth, D. Westermann et al., A novel and universal method for microRNA RT-qPCR data normalization, Genome Biology, vol.10, issue.6, 2009.
DOI : 10.1186/gb-2009-10-6-r64

D. Basso, F. Pesarin, L. Salmaso, and A. Solari, Permutation Tests for Stochastic Ordering and ANOVA, Statistics, vol.194, pp.1-35, 2009.

A. Alexa, J. Rahnenfuhrer, and T. Lengauer, Improved scoring of functional groups from gene expression data by decorrelating GO graph structure, Bioinformatics, vol.22, issue.13, pp.1600-1607, 2006.
DOI : 10.1093/bioinformatics/btl140

G. Ontology, GO) database. [cited; Available from: [http://www.geneontology

Z. Deng, J. Chen, and D. Wang, Transgenic overexpression of miR-133a in skeletal muscle, BMC Musculoskeletal Disorders, vol.455, issue.7209, p.21615921, 2011.
DOI : 10.1038/nature07242

I. Guller and A. Russell, MicroRNAs in skeletal muscle: their role and regulation in development, disease and function, The Journal of Physiology, vol.32, issue.21, pp.4075-87, 2010.
DOI : 10.1113/jphysiol.2010.194175

A. Koutsoulidou, N. Mastroyiannopoulos, D. Furling, J. Uney, and L. Phylactou, Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle, BMC Developmental Biology, vol.11, issue.1, 2011.
DOI : 10.1186/1471-2105-7-85
URL : https://hal.archives-ouvertes.fr/inserm-00668415

J. Chen, E. Mandel, J. Thomson, Q. Wu, and T. Callis, The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation, Nature Genetics, vol.132, issue.2, pp.228-261, 2006.
DOI : 10.1038/ng1725

S. Takada, E. Berezikov, Y. Yamashita, M. Lagos-quintana, and W. Kloosterman, Mouse microRNA profiles determined with a new and sensitive cloning method, Nucleic Acids Research, vol.34, issue.17, pp.115-125, 2006.
DOI : 10.1093/nar/gkl653

W. Luo, Q. Nie, and X. Zhang, MicroRNAs Involved in Skeletal Muscle Differentiation, Journal of Genetics and Genomics, vol.40, issue.3, pp.107-123, 2013.
DOI : 10.1016/j.jgg.2013.02.002

P. Rao, R. Kumar, M. Farkhondeh, S. Baskerville, and H. Lodish, Myogenic factors that regulate expression of muscle-specific microRNAs, Proceedings of the National Academy of Sciences, vol.103, issue.23, pp.8721-8727, 2006.
DOI : 10.1073/pnas.0602831103

D. Cacchiarelli, I. Legnini, J. Martone, V. Cazzella, D. Amico et al., miRNAs as serum biomarkers for Duchenne muscular dystrophy, EMBO Molecular Medicine, vol.102, issue.5, pp.258-65, 2011.
DOI : 10.1002/emmm.201100133
URL : https://hal.archives-ouvertes.fr/pasteur-00976762

T. Roberts, K. Blomberg, G. Mcclorey, E. Andaloussi, S. Godfrey et al., Expression Analysis in Multiple Muscle Groups and Serum Reveals Complexity in the MicroRNA Transcriptome of the mdx Mouse with Implications for Therapy, Molecular Therapy - Nucleic Acids, vol.1, p.23344181, 2012.
DOI : 10.1038/mtna.2012.26

S. Cheli, S. Francois, B. Bodega, F. Ferrari, and E. Tenedini, Expression Profiling of FSHD-1 and FSHD-2 Cells during Myogenic Differentiation Evidences Common and Distinctive Gene Dysregulation Patterns, PLoS ONE, vol.104, issue.43, p.21695143, 2011.
DOI : 10.1371/journal.pone.0020966.s003

J. Barbet, G. Butler-browne, and V. Mouly, [Main steps in the skeletal myogenesis in man, C R Seances Soc Biol Fil, vol.188, pp.585-92, 1994.

J. Barbet, L. Thornell, and G. Butler-browne, Immunocytochemical characterisation of two generations of fibers during the development of the human quadriceps muscle, Mechanisms of Development, vol.35, issue.1, pp.3-11, 1991.
DOI : 10.1016/0925-4773(91)90036-6

G. Butler-browne, J. Barbet, and L. Thornell, Myosin heavy and light chain expression during human skeletal muscle development and precocious muscle maturation induced by thyroid hormone, Anatomy and Embryology, vol.181, issue.6, 1990.
DOI : 10.1007/BF00174624

T. Huang, M. Zhu, X. Li, and S. Zhao, Discovery of Porcine microRNAs and Profiling from Skeletal Muscle Tissues during Development, PLoS ONE, vol.17, issue.2, p.18795099, 2008.
DOI : 10.1371/journal.pone.0003225.s009

X. Wang, Z. Hu, J. Klein, L. Zhang, and F. Fang, Decreased miR-29 Suppresses Myogenesis in CKD, Journal of the American Society of Nephrology, vol.22, issue.11, pp.2068-76, 2011.
DOI : 10.1681/ASN.2010121278

S. Shan, D. Lee, Z. Deng, T. Shatseva, and Z. Jeyapalan, MicroRNA MiR-17 retards tissue growth and represses fibronectin expression, Nature Cell Biology, vol.11, issue.8, pp.1031-1039, 2009.
DOI : 10.1371/journal.pone.0000116

D. Song, J. Ryu, J. Kim, E. Kwon, and H. Kim-do, family positively regulates cardiomyocyte hypertrophy by targeting atrogin-1 and MuRF-1, Biochemical Journal, vol.24, issue.1, pp.151-62, 2014.
DOI : 10.1161/CIRCRESAHA.112.300658

W. Kuang, J. Tan, Y. Duan, J. Duan, and W. Wang, Cyclic stretch induced miR-146a upregulation delays C2C12 myogenic differentiation through inhibition of Numb, Biochemical and Biophysical Research Communications, vol.378, issue.2, pp.259-63, 2009.
DOI : 10.1016/j.bbrc.2008.11.041

M. Brock, V. Samillan, M. Trenkmann, C. Schwarzwald, and S. Ulrich, AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension, European Heart Journal, vol.35, issue.45, pp.3203-3214, 2012.
DOI : 10.1093/eurheartj/ehs060

Y. Tang, D. Liu, L. Zhang, S. Ingvarsson, and H. Chen, Quantitative Analysis of miRNA Expression in Seven Human Foetal and Adult Organs, PLoS ONE, vol.67, issue.10, p.22194897, 2011.
DOI : 10.1371/journal.pone.0028730.s001

A. Legesse-miller, O. Elemento, S. Pfau, J. Forman, and S. Tavazoie, let-7 Overexpression Leads to an Increased Fraction of Cells in G2/M, Direct Down-regulation of Cdc34, and Stabilization of Wee1 Kinase in Primary Fibroblasts, Journal of Biological Chemistry, vol.284, issue.11, pp.6605-6614, 2009.
DOI : 10.1074/jbc.C900002200

C. Crist, D. Montarras, G. Pallafacchina, D. Rocancourt, and A. Cumano, Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression, Proceedings of the National Academy of Sciences, vol.106, issue.32, pp.13383-13390, 2009.
DOI : 10.1073/pnas.0900210106
URL : https://hal.archives-ouvertes.fr/pasteur-00429032

J. He, S. Jiang, F. Li, X. Zhao, and E. Chu, MicroRNA-30b-5p Is Involved in the Regulation of Cardiac Hypertrophy by Targeting CaMKII??, Journal of Investigative Medicine, vol.61, issue.3, pp.604-616, 2013.
DOI : 10.2310/JIM.0b013e3182819ac6

A. Flynt, N. Li, E. Thatcher, L. Solnica-krezel, and J. Patton, Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate, Nature Genetics, vol.15, issue.2, pp.259-63, 2007.
DOI : 10.1038/ng1953

E. Van-rooij, D. Quiat, B. Johnson, L. Sutherland, and X. Qi, A Family of microRNAs Encoded by Myosin Genes Governs Myosin Expression and Muscle Performance, Developmental Cell, vol.17, issue.5, pp.662-73, 2009.
DOI : 10.1016/j.devcel.2009.10.013

S. Lassche, G. Stienen, T. Irving, S. Van-der-maarel, and N. Voermans, Sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy, Neurology, vol.80, issue.8, pp.733-740, 2013.
DOI : 10.1212/WNL.0b013e318282513b

P. Dmitriev, L. Stankevicins, E. Ansseau, A. Petrov, and A. Barat, Defective Regulation of MicroRNA Target Genes in Myoblasts from Facioscapulohumeral Dystrophy Patients, Journal of Biological Chemistry, vol.288, issue.49, pp.34989-5002, 2013.
DOI : 10.1074/jbc.M113.504522

N. Harafuji, P. Schneiderat, M. Walter, and Y. Chen, miR-411 is up-regulated in FSHD myoblasts and suppresses myogenic factors, Orphanet Journal of Rare Diseases, vol.8, issue.1, p.23561550, 2013.
DOI : 10.1016/j.ajpath.2012.07.007

P. Arashiro, I. Eisenberg, A. Kho, A. Cerqueira, and M. Canovas, Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers, Proceedings of the National Academy of Sciences, vol.106, issue.15, pp.6220-6225, 2009.
DOI : 10.1073/pnas.0901573106

I. Eisenberg, A. Eran, I. Nishino, M. Moggio, and C. Lamperti, Distinctive patterns of microRNA expression in primary muscular disorders, Proceedings of the National Academy of Sciences, vol.104, issue.43, pp.17016-17037, 2007.
DOI : 10.1073/pnas.0708115104

S. Greco, A. Perfetti, P. Fasanaro, R. Cardani, and M. Capogrossi, Deregulated MicroRNAs in Myotonic Dystrophy Type 2, PLoS ONE, vol.39, issue.6, p.22768114, 2012.
DOI : 10.1371/journal.pone.0039732.s011

P. Dmitriev, A. Barat, A. Polesskaya, O. Connell, M. Robert et al., Simultaneous miRNA and mRNA transcriptome profiling of human myoblasts reveals a novel set of myogenic differentiation-associated miRNAs and their target genes, BMC Genomics, vol.14, issue.1, pp.265-275, 2013.
DOI : 10.1186/1471-2164-14-265
URL : https://hal.archives-ouvertes.fr/inserm-00819393

L. Geng, Z. Yao, L. Snider, A. Fong, and J. Cech, DUX4 Activates Germline Genes, Retroelements, and Immune Mediators: Implications for Facioscapulohumeral Dystrophy, Developmental Cell, vol.22, issue.1, pp.38-51, 2012.
DOI : 10.1016/j.devcel.2011.11.013

N. Caruso, B. Herberth, M. Bartoli, F. Puppo, and J. Dumonceaux, Deregulation of the Protocadherin Gene FAT1 Alters Muscle Shapes: Implications for the Pathogenesis of Facioscapulohumeral Dystrophy, PLoS Genetics, vol.107, issue.6, p.23785297, 2013.
DOI : 10.1371/journal.pgen.1003550.s017
URL : https://hal.archives-ouvertes.fr/hal-00862092

D. Gabellini, D. 'antona, G. Moggio, M. Prelle, A. Zecca et al., Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1, Nature, vol.302, pp.973-980, 2006.
DOI : 10.1038/nature04422

J. Gabriels, M. Beckers, H. Ding, D. Vriese, A. Plaisance et al., Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element, Gene, vol.236, issue.1, pp.25-32, 1999.
DOI : 10.1016/S0378-1119(99)00267-X

P. Reed, A. Corse, N. Porter, K. Flanigan, and R. Bloch, Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy, Experimental Neurology, vol.205, issue.2, pp.583-589, 2007.
DOI : 10.1016/j.expneurol.2007.03.009

L. Huang, K. Durick, J. Weiner, J. Chun, and S. Taylor, D-AKAP2, a novel protein kinase A anchoring protein with a putative RGS domain, Proceedings of the National Academy of Sciences, vol.94, issue.21, pp.11184-11193, 1997.
DOI : 10.1073/pnas.94.21.11184

F. Mcnab, R. Rajsbaum, J. Stoye, O. Garra, and A. , Tripartite-motif proteins and innate immune regulation, Current Opinion in Immunology, vol.23, issue.1, pp.46-56, 2011.
DOI : 10.1016/j.coi.2010.10.021

C. Vanderplanck, E. Ansseau, S. Charron, N. Stricwant, and A. Tassin, The FSHD Atrophic Myotube Phenotype Is Caused by DUX4 Expression, PLoS ONE, vol.6, issue.10, p.22053214, 2011.
DOI : 10.1371/journal.pone.0026820.s007

L. Wallace, S. Garwick, W. Mei, A. Belayew, and F. Coppee, , a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo, Annals of Neurology, vol.107, issue.3, pp.540-52, 2010.
DOI : 10.1002/ana.22275

J. De-greef, R. Lemmers, P. Camano, J. Day, and S. Sacconi, Clinical features of facioscapulohumeral muscular dystrophy 2, Neurology, vol.75, issue.17, pp.1548-54, 2010.
DOI : 10.1212/WNL.0b013e3181f96175

P. Van-overveld, R. Lemmers, L. Sandkuijl, L. Enthoven, and S. Winokur, Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy, Nature Genetics, vol.35, issue.4, pp.315-322, 2003.
DOI : 10.1038/ng1262

S. Winokur, K. Barrett, J. Martin, J. Forrester, and M. Simon, Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress, Neuromuscular Disorders, vol.13, issue.4, pp.322-355, 2003.
DOI : 10.1016/S0960-8966(02)00284-5